SHIRVAN MITCHELL (CSO and CDO) sold 45.0% of their position (22.82K shares) of SILEXION THERAPEUTICS CORP on the open market
Open‑market sale worth $31.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/30/2026ACC: 0001178913-26-001858
Officer· CSO and CDO
Since Feb 2026
-22.82K
Net shares
Net seller
$31.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
22.82K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−22.82K
Price / share
$1.36
Trade value
$31.03K
% of position
45.0%
3/26/2026
50.71K→27.89K
Total
Net shares
−22.82K
Net value
-$31.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/26/2026 | S · Sale | −22.82K | $1.36 | $31.03K | 45.0% | 50.71K | 27.89K |
| Total | −22.82K | -$31.03K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Stock Option (right to buy Ordinary Shares)
DirectUnderlying security
Ordinary Shares
Underlying shares
478.00
Shares owned
478.00
Exercise price
907.71
Expiration
—
Exercise window
—
Total
Underlying
478.00
Owned
478.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy Ordinary Shares) Direct | Ordinary Shares | 907.71 | — | — | 478.00 | 478.00 |
| Total | 478.00 | 478.00 | ||||